These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 28604509)

  • 21. Safety and Efficacy of Granulocyte/Monocyte Apheresis in Steroid-Dependent Active Ulcerative Colitis with Insufficient Response or Intolerance to Immunosuppressants and/or Biologics [the ART Trial]: 12-week Interim Results.
    Dignass A; Akbar A; Hart A; Subramanian S; Bommelaer G; Baumgart DC; Grimaud JC; Cadiot G; Makins R; Hoque S; Bouguen G; Bonaz B
    J Crohns Colitis; 2016 Jul; 10(7):812-20. PubMed ID: 26818659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical evaluation of granulocyte/monocyte apheresis therapy for active ulcerative colitis.
    Kanke K; Nakano M; Hiraishi H; Terano A
    Dig Liver Dis; 2004 Dec; 36(12):811-7. PubMed ID: 15646427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Granulocyte/monocyte adsorptive apheresis for the treatment of therapy-refractory chronic active ulcerative colitis.
    Dignass A; Akbar A; Baumgart DC; Bommelaer G; Bouguen G; Cadiot G; Gillessen A; Grimaud JC; Hart A; Hoque S; Makins R; Michiels C; Moreau J; Premchand P; Ramlow W; Schanz S; Subramanian S; von Tirpitz C; Bonaz B
    Scand J Gastroenterol; 2018 Apr; 53(4):442-448. PubMed ID: 29513111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of granulocyte apheresis in pediatric patients with ulcerative colitis: a pilot study.
    Ikeda H; Ishimaru Y; Takayasu H; Fujino J; Kisaki Y; Otani Y; Yamagishi J; Tahara K
    J Pediatr Gastroenterol Nutr; 2006 Nov; 43(5):592-6. PubMed ID: 17130733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The combination of granulocyte-monocyte apheresis and vedolizumab: A new treatment option for ulcerative colitis?
    Rodríguez-Lago I; Benítez JM; Sempere L; Sáez-González E; Barreiro-de Acosta M; de Zárate JO; Cabriada JL
    J Clin Apher; 2019 Dec; 34(6):680-685. PubMed ID: 31518013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Faecal calprotectin level for assessing endoscopic activity and predicting future clinical course in patients with moderately active ulcerative colitis undergoing granulomonocytapheresis: a prospective cohort study.
    Shimoyama T; Yamamoto T; Umegae S; Matsumoto K
    BMC Gastroenterol; 2018 Aug; 18(1):120. PubMed ID: 30068300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA and granulocyte-monocyte adsorption apheresis combotherapy after inadequate response to anti-TNF agents in ulcerative colitis.
    Sáez-González E; Moret-Tatay I; Bastida G; Aguas M; Iborra M; Nos P; Beltrán B
    J Clin Apher; 2024 Feb; 39(1):e22101. PubMed ID: 38054256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adsorptive depletion of elevated proinflammatory CD14+CD16+DR++ monocytes in patients with inflammatory bowel disease.
    Hanai H; Iida T; Takeuchi K; Watanabe F; Yamada M; Kikuyama M; Maruyama Y; Iwaoka Y; Hirayama K; Nagata S; Takai K
    Am J Gastroenterol; 2008 May; 103(5):1210-6. PubMed ID: 18177452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A pilot open-labeled prospective randomized study between weekly and intensive treatment of granulocyte and monocyte adsorption apheresis for active ulcerative colitis.
    Sakuraba A; Sato T; Naganuma M; Morohoshi Y; Matsuoka K; Inoue N; Takaishi H; Ogata H; Iwao Y; Hibi T
    J Gastroenterol; 2008; 43(1):51-6. PubMed ID: 18297436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adsorptive Granulocyte and Monocyte Apheresis in the Treatment of Ulcerative Colitis: The First Multicenter Study in China.
    Lai YM; Yao WY; He Y; Jiang X; Gu YB; Chen MH; Liu YL; Yuan YZ; Qian JM
    Gut Liver; 2017 Mar; 11(2):216-225. PubMed ID: 27843131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors associated with early outcomes following standardised therapy in children with ulcerative colitis (PROTECT): a multicentre inception cohort study.
    Hyams JS; Davis S; Mack DR; Boyle B; Griffiths AM; LeLeiko NS; Sauer CG; Keljo DJ; Markowitz J; Baker SS; Rosh J; Baldassano RN; Patel A; Pfefferkorn M; Otley A; Heyman M; Noe J; Oliva-Hemker M; Rufo P; Strople J; Ziring D; Guthery SL; Sudel B; Benkov K; Wali P; Moulton D; Evans J; Kappelman MD; Marquis A; Sylvester FA; Collins MH; Venkateswaran S; Dubinsky M; Tangpricha V; Spada KL; Britt A; Saul B; Gotman N; Wang J; Serrano J; Kugathasan S; Walters T; Denson LA
    Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):855-868. PubMed ID: 28939374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Granulocyte-monocyte apheresis for the treatment of inflammatory bowel disease].
    ; Passalacqua S; Ferraro PM
    G Ital Nefrol; 2012; 29 Suppl 54():S61-3. PubMed ID: 22388832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of apheresis as maintenance therapy for patients with ulcerative colitis in an open-label prospective multicenter randomised controlled trial.
    Naganuma M; Yokoyama Y; Motoya S; Watanabe K; Sawada K; Hirai F; Yamamoto T; Hanai H; Omori T; Kanai T; Hibi T;
    J Gastroenterol; 2020 Apr; 55(4):390-400. PubMed ID: 31811562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mucosal features and granulocyte-monocyte-apheresis in steroid-dependent/refractory ulcerative colitis.
    D'Ovidio V; Aratari A; Viscido A; Marcheggiano A; Papi C; Capurso L; Caprilli R
    Dig Liver Dis; 2006 Jun; 38(6):389-94. PubMed ID: 16569521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors affecting short- and long-term effects of leukocyte removal therapy in active ulcerative colitis.
    Nakano R; Iwakiri R; Ikeda Y; Kishi T; Tsuruoka N; Shimoda R; Sakata Y; Yamaguchi K; Fujimoto K
    J Gastroenterol Hepatol; 2013 Feb; 28(2):303-8. PubMed ID: 23339387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Granulocyte-monocyte apheresis: an alternative combination therapy after loss of response to anti-TNF agents in ulcerative colitis.
    Rodríguez-Lago I; Sempere L; Gutiérrez A; Núñez A; Leo Carnerero E; Hinojosa E; Mora M; Cañete F; Mañosa M; Herrera C; Beltrán B; Forés A; Arjona D; Barreiro-de Acosta M; Khorrami S; Aguirre U; Ginard D; Cabriada JL
    Scand J Gastroenterol; 2019 Apr; 54(4):459-464. PubMed ID: 30982369
    [No Abstract]   [Full Text] [Related]  

  • 37. Addition of Granulocyte/Monocyte Apheresis to Oral Prednisone for Steroid-dependent Ulcerative Colitis: A Randomized Multicentre Clinical Trial.
    Domènech E; Panés J; Hinojosa J; Annese V; Magro F; Sturniolo GC; Bossa F; Fernández F; González-Conde B; García-Sánchez V; Dignass A; Herrera JM; Cabriada JL; Guardiola J; Vecchi M; Portela F; Ginard D;
    J Crohns Colitis; 2018 May; 12(6):687-694. PubMed ID: 29490024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting neutrophils in inflammatory bowel disease: revisiting the role of adsorptive granulocyte and monocyte apheresis.
    Bamias G; Zampeli E; Domènech E
    Expert Rev Gastroenterol Hepatol; 2022 Aug; 16(8):721-735. PubMed ID: 35833363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intermittent granulocyte and monocyte apheresis versus mercaptopurine for maintaining remission of ulcerative colitis: a pilot study.
    Sakuraba A; Sato T; Morohoshi Y; Matsuoka K; Okamoto S; Inoue N; Takaishi H; Ogata H; Iwao Y; Hibi T
    Ther Apher Dial; 2012 Jun; 16(3):213-8. PubMed ID: 22607563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and effectiveness of granulocyte and monocyte adsorptive apheresis in patients with inflammatory bowel disease in special situations: a multicentre cohort study.
    Motoya S; Tanaka H; Shibuya T; Osada T; Yamamoto T; Hongo H; Mizuno C; Saito D; Aoyama N; Kobayashi T; Ito H; Tanida S; Nojima M; Kokuma S; Hosoi E
    BMC Gastroenterol; 2019 Nov; 19(1):196. PubMed ID: 31752695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.